Two French innovations to better take his medical treatments

How to make sure that people take their medical treatments effectively? Two French companies have developed technologies to improve health.

FRANCE MOVES

Too many deaths or medical complications are due to drugs that are poorly taken, not taken or poorly prescribed. This is the finding made by the founders of MedinCell and Synapse Medicine. In France moves on Monday Europe 1, Raphaëlle Duchemin puts a spotlight on these two French companies that innovate to stop this phenomenon.

MedinCell, long-acting injectable treatments

On average, one patient in two does not start or does not finish treatment. It is starting from this alarming fact that Christophe Douat, founder of MedinCell, a company based in Montpellier, has been thinking about a new way to take his medication. With his team, he developed a method of injection, which slowly diffuses the product in the body.

"One patient in two does not start or take his treatment.That's bad for the patient and it is extremely expensive for the health system" says Christophe Douat, who founded @MedinCell, long-acting injectable treatments! @ DucheminRapha # Europe1pic.twitter.com / sioBF4BJd4

"The injection forms a ball the size of a pea under the skin.This small ball will degrade under the effect of water under the skin, and will release the drug in a secure way for a selected period" , he describes at the microphone of Europe 1. Very flexible, the technology developed by MedinCell can adapt to the medical need according to the disease to be treated.

"In our most advanced treatments for schizophrenia, we are on periods of one or two months.For anesthesia, we are on a week," he says. Interested in the product, the Bill and Melinda Gates Foundation chose the Montpellier-based company to develop an injection-controlled contraceptive system, effective over a period of six months. Currently, MedinCell is working hard on anti-rejection therapy after an organ transplant, and thus avoid patients thinking about taking medication daily until the end of their life.

>> From 13h to 14h, France moves with Raphaëlle Duchemin on Europe 1. Find the replay of the show here

In some cases, the patient will be able to inject himself / herself, which will free up time for doctors or caregivers. "The advantage of our technology is that we can remove the little ball under the skin if necessary", also ensures Christophe Douat.

Technology has other benefits, including ecological ones. "You do not want to pack the medicine boxes, you also avoid the case where the patient, having not taken his treatment, ends up throwing it in the trash instead of bringing it back to the pharmacy. water, "says Christophe Douat. He also says that this technology will be financially attractive: "With the help of the Gates Foundation, we will achieve prices of less than $ 2 per injection for six months."

Synapse Medicine, artificial intelligence at the service of prescription drugs

Between 10,000 and 12,000 deaths are made each year from misuse of the drug. To avoid this, Clément Goehrs, doctor, imagined a platform of artificial intelligence to accompany doctors in their prescriptions, and save time. "We must realize that today, prescribe well or deliver a drug, it has become extremely complex.It is necessary to get information on the patient and the drug, in 5, 10, 20 different sources" , he explains on Europe 1.

"You have to realize that prescribing is complex, so at @SynapseMed, we have algorithms that run through medication records, institutional sources, to have a medical knowledge that is always up-to-date and reliable"
@ # DucheminRapha Europe1pic.twitter.com / 9PU5FRb9Gz

That's how, 18 months ago, Clement Goehrs founded Synapse Medicine. How it works ? "We have algorithms that tirelessly, every night, run through these famous sources of reference on the drug (the leaflets, but also reference sources published by the Haute Autorité de Santé) .To allow to have a medical knowledge always up to date. , always reliable at the scale of the day, "he explains. "A health professional can ask the platform how to prescribe this or that drug to a patient with kidney failure, and Synapse will respond."

Since the platform was officially launched in March, hundreds of physicians, as well as hospitals and teleconsultation services, have been using this technology.